Inflammation likely plays a key role in T2D outcomes, and various anti-inflammatory treatments may improve both T2D and its ...
As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...
Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...
Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...
As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...
With chronic illnesses like cancer, heart disease, and diabetes on the rise – in fact, it is believed that some 60% of adults ...
Everyday Health on MSN

5 Myths About GLP-1s for Weight Loss

Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...
Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group of companies that is populated mainly by tech giants.
WHO issues global guideline on the use of GLP-1 medicines in treating obesity: Geneva Wednesday, December 3, 2025, 14:00 Hrs [IST] To address the growing global health challenge o ...
Obesity remains a pressing global health challenge and was linked to 3.7 million deaths in 2024. - Kenya breaking news | Kenya news today | Capitalfm.co.ke ...
“From an NP viewpoint, these demand signals translate into job openings and practice models that include injectables, lasers, ...